GGrantIndex
Sort

146,196 grants matching diabetes

CDK6 AS A NOVEL THERAPEUTIC TARGET FOR TYPE II DIABETES

$2,084,572
Tufts Medical Center Parent, Inc. · · FY2019 · Defense Health Agency

Alzheimer's dementia onset and progression in international cohorts (Amended)

$2,083,798
Colin Masters · University Of Melbourne · R01 · FY2022 · AG

Plasma proteomics in CHS and population biology

$2,083,439
Bruce M Psaty · University Of Washington · R01 · FY2020 · HL

Mentoring Translational Cancer Research in Oklahoma

$2,083,290
Danny N. Dhanasekaran · University Of Oklahoma Hlth Sciences Ctr · P20 · FY2014 · GM

Arterial Dysfunction: Basic and Clinical Mechanisms

$2,083,243
Brigham And Women'S Hospital · P01 · FY2005 · HL

MENTORING IN CARDIOVASCULAR BIOLOGY

$2,083,023
Louisiana State Univ Hsc New Orleans · P20 · FY2004 · RR

Structural Genomics on Membrane Proteins

$2,082,938
Wayne A. Hendrickson · New York Structural Biology Center · U54 · FY2011 · GM

MAINTENANCE AND UPDATE OF THE UNITED STATES RENAL DATA SYSTEM (USRDS)

$2,080,822
Kirsten Johansen · Hennepin Healthcare Research Institute · N01 · FY2021 · HD

Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury

$2,080,616
Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA

Development of MMP-9 inhibitory monoclonal antibodies to relieve neuropathic pain

$2,079,796
Xin Ge · University Of Texas Hlth Sci Ctr Houston · UG3 · FY2025 · NS

Exposures, Health Impacts, and Risk for Mine Waste Contamination

$2,079,448
Xinxin Ding · University Of Arizona · P42 · FY2024 · ES

Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)

$2,079,261
Sabra L Klein · Johns Hopkins University · U54 · FY2022 · CA

MENTORING IN CARDIOVASCULAR BIOLOGY

$2,078,991
Daniel R Kapusta · Lsu Health Sciences Center · P20 · FY2006 · RR

Family and Neighborhood Interventions to Reduce Heart Disease Risk in East L.A.

$2,078,502
Alexander N Ortega · University Of California Los Angeles · P50 · FY2014 · HL

Native-Controlling Hypertension And Risk through Technology (Native-CHART)

$2,078,480
Dedra S Buchwald · Washington State University · U54 · FY2016 · MD

PREVENTABLE Data Coordinating Center

$2,077,632
Bradley G Hammill · Duke University · U19 · FY2023 · AG

GENERAL CLINICAL RESEARCH CENTER

$2,077,270
Richard N Fine · State University New York Stony Brook · M01 · FY2007 · RR

Membrane-Mediated Alterations in Diabetes

$2,077,068
Richard W Gross · Washington University · P01 · FY2012 · HL

Vascular Inflammation and Atherosclerosis

$2,076,482
Bradford C Berk · University Of Rochester · P01 · FY2009 · HL

Molecular-Genetic Mechs Underlying Effects of Anti-inflammatory/Analgesic Drugs

$2,076,127
Xiao-Min Wang · National Institute Of Nursing Research · ZIA · FY2010 · NR

Einstein-Mount Sinai Diabetes Research Center

$2,076,043
Jeffrey E Pessin · Albert Einstein College Of Medicine · P30 · FY2020 · DK

Arterial Dysfunction: Basic and Clinical Mechanisms

$2,075,839
Thomas Michel · Brigham And Women'S Hospital · P01 · FY2006 · HL

WISCONSIN: HEALTHY COMMUNITIES, TOBACCO CONTROL, DIABETES PREVENTION AND CONTROL,

$2,075,373
Mark V Wegner · Wisconsin Department Of Health Services · U58 · FY2011 · DP

Mechanism Of Action And Functions Of The Gli-related Proteins Glis 1-3

$2,075,075
Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES

Genes, environmental stressors, and the biobehavioral pathways to CVD

$2,075,030
Redford B Williams · Duke University · P01 · FY2019 · HL